Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Cannabinoid antagonist SR-141716 may be effective in treatment of alcoholism and appetite disorders

Aug. 19, 1998

Nonamine compounds inhibit monoamine transporters, contrary to prevailing beliefs

Aug. 18, 1998

Combination therapy with naltrexone, TA-0910 and fluoxetine is an effective treatment for alcoholism

Aug. 17, 1998

Rockefeller University scientists delve into the genetic roots of addiction

Aug. 12, 1998

Vigabatrin is effective for treating alcohol withdrawal syndrome

July 22, 1998

GV-150013 has dual therapeutic potential in treating alcoholism and sleep disorders

July 22, 1998

Calcium channel blockers reduce craving for alcohol

July 21, 1998

FDA accepts license applications for CroTAb

July 20, 1998

Dopamine transporter ligand shows potential in cocaine abuse

July 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 22, 2025.
Makary’s vision for slimmed-down US FDA somewhat reassuring
BioWorld
Nearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s...
Dupixent bounces back in treating hives with FDA approval
BioWorld
The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for...
Ouch! Tariffs hit med tech harder than expected
BioWorld MedTech
First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...